Kiesewetter et al., 1984 - Google Patents
Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues of immature ratsKiesewetter et al., 1984
View PDF- Document ID
- 332496590014762342
- Author
- Kiesewetter D
- Kilbourn M
- Landvatter S
- Heiman D
- Katzenellenbogen J
- Welch M
- Publication year
- Publication venue
- J Nucl Med
External Links
Snippet
The measurement of the estrogen-receptor content of human breast tumors has proved useful in selecting the most suitable form of treatment for metastatic disease: in general, tumors devoid of estrogen receptor are not responsive to hormonal therapy, whereas those …
- 239000000262 estrogen 0 title abstract description 23
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
- A61K51/1003—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody not used, see subgroups
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody not used, see subgroups against animal or human tumor cells or tumor cell determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kiesewetter et al. | Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues of immature rats | |
| Katzenellenbogen et al. | 16α-[77Br] bromoestradiol-17β: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and induced mammary tumors | |
| Wilbur et al. | Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer | |
| Tattersall et al. | Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease | |
| US5219548A (en) | High affinity halogenated-tamoxifen derivatives and uses thereof | |
| Pomper et al. | 11. beta.-methoxy-, 11. beta.-ethyl, and 17. alpha.-ethynyl-substituted 16. alpha.-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity | |
| Kojima et al. | New adrenal-scanning agent | |
| Hanson et al. | Preparation and evaluation of 17α-[125I] iodovinyl-11β-methoxyestradiol as a highly selective radioligand for tissues containing estrogen receptors: concise communication | |
| Hatano et al. | D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2 | |
| Jagoda et al. | [I-125] 17α-Iodovinyl 11β-methoxyestradiol: in vivo and in vitro properties of a high-affinity estrogen-receptor radiopharmaceutical | |
| Jonson et al. | PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins | |
| ZIELINSKI et al. | 16 α-[125I] Iodo-11 β Methoxy-17 β-Estradiol: A Radiochemical Probe for Estrogen-Sensitive Tissues | |
| Vanbrocklin et al. | Preparation and evaluation of 17-ethynyl-substituted 16α-[18F] fluoroestradiols: selective receptor-based PET imaging agents | |
| Xu et al. | 18F–labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer | |
| McLaughlin et al. | Cytotoxicity of Receptor-Mediated 16α [125I] Iodo-estradiol in Cultured MCF-7 Human Breast Cancer Cells | |
| US5208338A (en) | Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans | |
| Fowler et al. | Synthesis and preliminary evaluation in animals of carrier-free 11C-1-dopamine hydrochloride: X | |
| CA1178885A (en) | ASSAY KIT CONTAINING 16.alpha. HALOGEN SUBSTITUTED 3,17.beta.-DIHYDROXY STEROIDAL ESTROGENS | |
| Muftuler et al. | 131I labeling of tamoxifen and biodistribution studies in rats | |
| Ali et al. | 2-and 4-Fluorinated 16. alpha.-[125I] iodoestradiol derivatives: synthesis and effect on estrogen receptor binding and receptor-mediated target tissue uptake | |
| Landvatter et al. | (2R*, 3S*)-1-[125I] Iodo-2, 3-bis (4-hydroxyphenyl) pentane ([125I] iodonorhexestrol), and (2R*, 3S*)-1-[77Br] bromo-2, 3-bis (4-hydroxyphenyl) pentane ([77Br] bromonorhexestrol), two. gamma.-emitting estrogens that show receptor-mediated uptake by target tissues in vivo | |
| Symes et al. | The synthesis of 16α-[131I] iodo-oestradiol and evaluation of its use as a radiotracer for oestrogen receptor positive breast tumours | |
| Hanson et al. | Synthesis and evaluation of (17α, 20E) 21-[125I] iodo-11-substituted-19-norpregna-1, 3, 5 (10), 20-tetraene-3, 17β-diols: the influence of 11-stereochemistry on tissue distribution of radioiodinated estrogens | |
| Eckelman et al. | Iodinated bleomycin: an unsatisfactory radiopharmaceutical for tumor localization | |
| Seo et al. | Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor |